Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 201 - 250 out of 1,825

Document Document Title
WO/2007/090295A1
This application relates to metal-containing coordination polymers having high birefringent values. For example, polymers having birefringent values within the range of 0.07 to 0.45 are described. The polymers may comprise units having t...  
WO/2007/091713A1
Disclosed is a polynuclear complex containing, in a molecule, a plurality of metal atoms and one or more ligands L satisfying the following conditions (i), (ii) and (iii). (i) It has a group having a polymerization-reactive multiple bond...  
WO/2007/091616A1
A polynuclear metal complex having in each molecule not only at least one large cyclic ligand having 5 to 15 coordinating atoms but also multiple metal atoms is subjected to any of heating treatment, radiation exposure treatment and elec...  
WO/2007/083395A1
A bisphosphonoamine compound represented by the following formula (I): wherein R1, R2, R3, R4 and R5 are independently an alkyl group having 1 to 6 carbon atoms, and n is an integer of 1 to 6, is extremely useful as an intermediate for p...  
WO/2007/079858A1
Transition metal complexes with a ligand of formula (I), where n1, n2 and n3 independently = 1 or 2 are used as catalytically effective activators for peroxy compounds in cleaning solutions for hard surfaces in particular for dish washin...  
WO/2007/073472A2
The present invention relates to a compound for use as a chelator in the radioactive labeling of biomolecules with metal tricarbonyl complexes, which compound has the general Formula (I) wherein M is a monovalent cation, such as Li, Na, ...  
WO/2007/001940A3
The present invention provides novel amino acid compounds useful in detecting and evaluating brain and body tumors. These compounds have the advantageous properties of rapid uptake and prolonged retention in tumors and can be labeled wit...  
WO/2007/001958A3
The radiolabeled non-natural amino acid 1-amino-3- cyclobutane-1-carboxylic acid (ACBC) and its analogs are candidate tumor imaging agents useful for positron emission tomography and single photon emission computed tomography due to thei...  
WO/2006/120133A3
The present invention concerns coloring keratin fibers, especially human hair, with colored metal complexes.  
WO/2007/012377A3
The invention relates to methods for the treatment of cells with electric fields in order to modify the membrane permeability of said cells with the aid of lipophilic ions as a medium additive. The invention more particularly relates to ...  
WO/2007/031773A1
An organic light-emitting device comprising: an anode; a cathode; a light-emitting layer located between the anode and the cathode, said light-emitting layer containing a light-emitting metal complex comprising general formula (1) where ...  
WO/2007/012377A2
The invention relates to methods for the treatment of cells with electric fields in order to modify the membrane permeability of said cells with the aid of lipophilic ions as a medium additive. The invention more particularly relates to ...  
WO/2007/001940A2
The present invention provides novel amino acid compounds useful in detecting and evaluating brain and body tumors. These compounds have the advantageous properties of rapid uptake and prolonged retention in tumors and can be labeled wit...  
WO/2007/001958A2
The radiolabeled non-natural amino acid 1-amino-3- cyclobutane-1-carboxylic acid (ACBC) and its analogs are candidate tumor imaging agents useful for positron emission tomography and single photon emission computed tomography due to thei...  
WO/2006/136564A1
Compounds of general formula (I): in which: R1, R2, R3, R4, R5 and FG are as defined in the specification and claims, optionally conjugated with a suitable molecule able to interact with physiological systems; and their chelates with bi-...  
WO/2006/120133A2
The present invention concerns coloring keratin fibers, especially human hair, with colored metal complexes.  
WO2005117907A3
Chiral ligands and metal complexes based on such chiral ligands useful in asymmetric catalysis are disclosed. The metal complexes according to the present invention are useful as catalysts in asymmetric reactions, such as, hydrogenation,...  
WO/2006/080993A1
This invention relates to novel cationic crown-ether containing metal complexes, methods of preparing the cationic crown-ether containing metal complexes, and radiopharmaceutical compositions comprising the cationic crown-ether containin...  
WO2006032780A8
The invention concerns compounds of formula (I) and their use as catalyst.  
WO2006037988A3
Novel radioactive technetium and rhenium complexes comprising tripodal ligands are provided by the present invention. In particular, Tc(I) complexes are provided by the present invention. Novel ligands suitable for the formation of the t...  
WO/2006/054466A1
A radioactive technetium complex that realizes enhancing of in a single photon discharge type tomogram, cardiac contrast and initial circulation extraction ratio; and a radioactive imaging diagnostic agent comprising the complex. The com...  
WO2005068074A3
The invention accordingly relates to the use as catalysts of at least one metal complex of formula (1) [LnMemXp]2Yq (1), wherein L is a ligand of formula (2) wherein Q1 is N or CR 10, Q2 is N or CR11, and wherein the remaining substituen...  
WO/2006/043110A1
Complex salts, based on ionic liquids, which exhibit at least one light emitting property selected from (a) fluorescence, (b) phosphorescence, and (c) electroluminescence when in the solid state; and which have a melting point below 250°C.  
WO/2006/041056A1
Disclosed is a metal-containing coordination compound represented by the formula (1) below and having characteristics equivalent to or better than those of metal complexes which can be polymerized or dissolved in a solvent. Also disclose...  
WO/2006/037988A2
Novel radioactive technetium and rhenium complexes comprising tripodal ligands are provided by the present invention. In particular, Tc(I) complexes are provided by the present invention. Novel ligands suitable for the formation of the t...  
WO/2006/032780A1
The invention concerns compounds of formula (I) and their use as catalyst.  
WO/2006/026855A1
The invention provides a method for manufacturing or preparing neutral, low molecular weight 99mTc-labeled and 186Re-labeled carbohydrate complexes with an improved radiochemical yield from a simple functionalized sugar, such as glucosam...  
WO/2006/024493A1
The invention relates to a novel method for producing organorhenium(VII) oxides  
WO/2006/015414A1
The present invention provides an IR-absorbing naphthalocyanine dye of formula (I): wherein M is selected from Si(A1)(A2), Ge(A1)(A2), Ga(A1), Mg, Al(A1), TiO, Ti(A1)(A2), ZrO, Zr(A1)(A2), VO, V(A1)(A2), Mn, Mn(A1), Fe, Fe(A1), Co, Ni, C...  
WO2005097123A3
The present invention relates to Pyridyl-Substituted Porphyrin Compounds, compositions comprising an effective amount of a Pyridyl-Substituted Porphyrin Compound and methods for treating or preventing injury due to exposure to a reactive...  
WO2005097808A3
Polyhydroxy hydrogensulfated trimetallic nitride endohedral metallofullerenes, can be utilized in a number of applications, for example, as proton conductors in electrochemical devices. The presence of encapsulated metal atoms, preferabl...  
WO2005077962A3
Compositions containing crowned dithiocarbamate metal complexes and methods of using these compositions; neutral and cationic radioactive metal-nitrido complexes of crowned dithiocarbamates (DTCs) and methods of using these complexes as ...  
WO/2005/117907A2
Chiral ligands and metal complexes based on such chiral ligands useful in asymmetric catalysis are disclosed. The metal complexes according to the present invention are useful as catalysts in asymmetric reactions, such as, hydrogenation,...  
WO/2005/116039A1
The present invention provides a novel class of molecular coordination compounds, and more particularly, square supramolecular metal coordination grids of the formula (I): [Ma2(L)2a]Xz (I), wherein M is a transition metal: a is 3, 4, 5 o...  
WO/2005/108330A1
The aim of the invention is to provide radiolytically and metabolically stable metal complexes, which are suitable for conjugation with biomolecules and to provide a method for their production. This is achieved by metal complexes based ...  
WO/2005/105303A1
The present invention relates to the use of certain manganese complexes having bispyridylpyrimidine or bispyridyltriazine ligands or mixtures of such ligands as catalysts for reactions with peroxy compounds for bleaching coloured stains ...  
WO/2005/097808A2
Polyhydroxy hydrogensulfated trimetallic nitride endohedral metallofullerenes, can be utilized in a number of applications, for example, as proton conductors in electrochemical devices. The presence of encapsulated metal atoms, preferabl...  
WO/2005/097123A2
The present invention relates to Pyridyl-Substituted Porphyrin Compounds, compositions comprising an effective amount of a Pyridyl-Substituted Porphyrin Compound and methods for treating or preventing injury due to exposure to a reactive...  
WO/2005/090371A1
A transition metal complex which is a bis-arylimine pyridine MXn complex, comprising a bis-arylimine pyridine ligand having the formula (I), wherein R1-R5, R7-R9, R12 and R14 are each, independently, hydrogen, optionally substituted hydr...  
WO/2005/087697A1
[PROBLEMS] To provide a metal complex capable of being suitably used for manufacturing a metal-containing thin film by the CVD method and a method for manufacturing a metal-containing thin film. [MEANS FOR SOLVING PROBLEMS] A metal compl...  
WO/2005/082894A1
The present invention relates to cell targeting conjugates and in particular, but not exclusively, to methods of their use in selectively eliminating and in selectively imaging target cells. The invention also relates to processes for pr...  
WO2005067388A3
The present invention relates to compounds that selectively bind to cells undergoing perturbations and alterations of their normal plasma membrane organization, such as cells undergoing apoptosis or activated platelets. The invention fur...  
WO/2005/079865A1
One aspect of the invention relates to complexes of a radionuclide with various heteroaryl ligands, e.g., imidazolyl and pyridyl ligands, and their use in radiopharmaceuticals for a variety of clinical diagnostic and therapeutic applicat...  
WO/2005/079866A1
One aspect of the invention relates to complexes of technetium (Tc) and rhenium (Re) with various heteroaromatic ligands, e.g., quinolinyl and isoquinolinyl ligands, and their use in fluoresence and radioimaging for a variety of clinical...  
WO/2005/077962A2
Compositions containing crowned dithiocarbamate metal complexes and methods of using these compositions; neutral and cationic radioactive metal-nitrido complexes of crowned dithiocarbamates (DTCs) and methods of using these complexes as ...  
WO/2005/067388A2
The present invention relates to compounds that selectively bind to cells undergoing perturbations and alterations of their normal plasma membrane organization, such as cells undergoing apoptosis or activated platelets. The invention fur...  
WO/2005/068074A2
The invention accordingly relates to the use as catalysts of at least one metal complex of formula (1) [LnMemXp]2Yq (1), wherein L is a ligand of formula (2) wherein Q1 is N or CR 10, Q2 is N or CR11, and wherein the remaining substituen...  
WO2005033119A9
The application discloses the use of supramolecular compounds as antitumour, antimicrobial (such as antibacterial and antiprotozoal) and antiviral agents. Such compounds comprise ligands as defined in the application coordinated to at le...  
WO2004043380A8
The present invention relates to compounds and related technetium and rhenium complexes thereof which are suitable for imaging or therapeutic treatment of tissues, organs, or tumors. In another embodiment, the invention relates the metho...  
WO/2005/044149A1
The present invention relates to hyaluronic acid polymers modified with non-proteinaceous catalysts for the dismutation of superoxide, and processes for making such materials. The invention further provides pharmaceutical compositions co...  

Matches 201 - 250 out of 1,825